W.R. Berkley’s DA32 Life Science Tech Acquisition Corp DALS Stock Holding History
Bought
Maintained
Sold
Other funds holding DALS
W.R. Berkley's DALS Position: Q3 2022 in Review
W.R. Berkley sold out of DA32 Life Science Tech Acquisition Corp (DALS) in Q3 2022, closing a stake of 157,016 shares — an estimated $1.52M sold.
W.R. Berkley first reported a position in DALS in Q3 2021 and held it in 4 quarters. The position peaked at $1.54M in Q3 2021. 43 funds tracked by Wall St. Rank hold DALS as of Q3 2022.
- W.R. Berkley reported no remaining DA32 Life Science Tech Acquisition Corp position as of Q3 2022 after selling out during the quarter.
- W.R. Berkley sold 157,016 DA32 Life Science Tech Acquisition Corp shares in Q3 2022, an estimated $1.52M.
- W.R. Berkley first reported a position in DA32 Life Science Tech Acquisition Corp in Q3 2021 and held it in 4 quarters.
- W.R. Berkley's DA32 Life Science Tech Acquisition Corp position peaked at $1.54M in Q3 2021.
- 43 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp as of Q3 2022.
Based on W.R. Berkley's 13F filing for Q3 2022, filed 14 Nov 2022.